Literature DB >> 26029460

Liver-directed conversion therapy in metastatic colon cancer.

Alexandra Snyder1, Nancy Kemeny1, Ali Shamseddine1, Ashwaq Al-Olayan1, Fadi El-Merhi1, David P Kelsen1, Faek Jamali1, Mustafa Sidani1, Deborah Mukherji1, Mahmoud El-Naghy1, Eileen M O'Reilly1, Leonard B Saltz1, Ghassan K Abou-Alfa1.   

Abstract

Entities:  

Year:  2015        PMID： 26029460      PMCID： PMC4397241          DOI： 10.3978/j.issn.2078-6891.2015.006

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  26 in total

1.  Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Authors:  Frank A Scappaticci; Louis Fehrenbacher; Thomas Cartwright; John D Hainsworth; William Heim; Jordan Berlin; Fairooz Kabbinavar; William Novotny; Somnath Sarkar; Herbert Hurwitz
Journal:  J Surg Oncol       Date:  2005-09-01       Impact factor: 3.454

Review 2.  Hepatic-arterial chemotherapy.

Authors:  N Kemeny; F Fata
Journal:  Lancet Oncol       Date:  2001-07       Impact factor: 41.316

3.  Evidence for breast cancer as an integral part of Lynch syndrome.

Authors:  Nicole Buerki; Lucienne Gautier; Michal Kovac; Giancarlo Marra; Mauro Buser; Hansjakob Mueller; Karl Heinimann
Journal:  Genes Chromosomes Cancer       Date:  2011-10-27       Impact factor: 5.006

Review 4.  Clinical pharmacology of hepatic arterial chemotherapy.

Authors:  W D Ensminger; J W Gyves
Journal:  Semin Oncol       Date:  1983-06       Impact factor: 4.929

5.  Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial.

Authors:  Carmen J Allegra; Greg Yothers; Michael J O'Connell; Saima Sharif; Nicholas J Petrelli; Samia H Lopa; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

6.  Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model.

Authors:  Paul K Newton; Jeremy Mason; Kelly Bethel; Lyudmila Bazhenova; Jorge Nieva; Larry Norton; Peter Kuhn
Journal:  Cancer Res       Date:  2013-02-27       Impact factor: 12.701

7.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

9.  Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

Authors:  Nancy E Kemeny; Fidel D Huitzil Melendez; Marinela Capanu; Philip B Paty; Yuman Fong; Lawrence H Schwartz; William R Jarnagin; Dina Patel; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 10.  Genetic determinants of cancer metastasis.

Authors:  Don X Nguyen; Joan Massagué
Journal:  Nat Rev Genet       Date:  2007-05       Impact factor: 53.242
View more
  1 in total

1.  Practice and Impact of Multidisciplinary Tumor Boards on Patient Management: A Prospective Study.

Authors:  Raghid N Charara; Firas Y Kreidieh; Rania A Farhat; Karine A Al-Feghali; Katia E Khoury; Ali Haydar; Lara Nassar; Ghina Berjawi; Ali Shamseddine; Nagi S El Saghir
Journal:  J Glob Oncol       Date:  2016-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.